n(6)-carboxymethyllysine has been researched along with Inflammatory Bowel Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrassy, M; Autschbach, F; Bierhaus, A; Chen, J; Humpert, PM; Igwe, J; Katus, HA; Kientsch-Engel, R; Liliensiek, B; Morcos, M; Nawroth, PP; Neurath, MF; Remppis, A; Schiekofer, S; Schleicher, E; Schmidt, AM; Stern, DM; Stremmel, W; Thiele, K; Volz, C; Wendt, T | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Posttranslationally modified proteins as mediators of sustained intestinal inflammation.
Topics: Adult; Animals; Calgranulin A; Calgranulin B; Cell Extracts; Disease Models, Animal; Endothelial Cells; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Lysine; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2006 |